Despite acknowledging its role in immunosuppression, the precise mechanisms by which VSIG-3 influences cancer pathogenesis remain elusive, with some reports, such as Johnston et al., challenging the specificity of the VISTA-VSIG-3 interaction (27). Here, IGSF11 is linked to cancer.